Skip to content
GLP-1 Scorecard
Menu
Graded #221

Amble

Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

Visit AmbleWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$179/mo (starting dose, compounded)
Tirzepatide
$289/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Weigh Amble against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Amble dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value60/100
Dose & formulation64/100
Clinical oversight79/100
Labs & monitoring52/100
Fulfillment81/100
Contract terms55/100

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Bottom line — Grade C

Best for: Shoppers who want mainstream telehealth GLP-1 access.

Ranked #221 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Amble — the realistic shortlist.

The 19 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Amble's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Amble's site. Not medical advice; see our disclosure.

← Back to the scorecard